According to Anand Tandon of Market Expert, the midcap pharma sector will continue to look quite attractive.
Anand Tandon of Market Expert told CNBC-TV18, "Many of the pharma companies now have pipelines which are looking very robust. The thing with pharma is that it takes a long time for a smaller company especially if it is in the API space to get its registration portfolio up to a certain size. So, it may take 5-10 years before that begins to happen and then at one time there is an inflection point which many of these companies have reached where that pipeline starts to translate into business. So, the midcap pharma sector will continue to look quite attractive. Valuations are not particularly stretched in the smaller companies though the frontline companies are a lot more aggressively priced."
Shasun Pharmaceuticals ended at Rs 272.30, up Rs 1.20, or 0.44 percent.
The share touched its 52-week high Rs 291.80 and 52-week low Rs 67.70 on 05 December, 2014 and 25 March, 2014, respectively.
Anda sedang membaca artikel tentang
Midcap pharma look attractive: Anand Tandon
Dengan url
http://untukkesehatanda.blogspot.com/2014/12/midcap-pharma-look-attractive-anand.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Midcap pharma look attractive: Anand Tandon
namun jangan lupa untuk meletakkan link
Midcap pharma look attractive: Anand Tandon
sebagai sumbernya
0 komentar:
Posting Komentar